This bill would establish a National Clinical Care Commission to evaluate and make recommendations about improvements to federal programs related to diabetes within the Dept. of Health and Human Services (HHS). It would be required to submit an operating plan to HHS and Congress describing how it will report on specified aspects of diabetes treatment within 90 days of its first meeting. The commission would be terminated after it submits a final report, which would be required before the end of fiscal year 2021.
The commission would report on:
HHS programs that focus on prevention;
Current activities and gaps in federal efforts to support clinicians in providing integrated care;
Improvement in federal education and awareness activities related to prevention and treatment;
Methods for outreach and dissemination of education and awareness materials;
Opportunities for consolidation of overlapping federal programs.
The commission would be composed of the heads of relevant federal agencies and one representative from each of the following categories:
Physician specialties, such as clinical endocrinologists, that play a role in the prevention or treatment of diseases and complications related to diabetes.
Primary care physicians.
Non-physician healthcare professionals.
National experts, including public health experts.
Healthcare providers with a patient population that consists of a high percentage of individuals who are enrolled in a state Medicaid program who aren’t covered under a health plan or health insurance coverage.